Syngene International Q1 Results: Profit Falls 18%, In Line With Estimates

Syngene International's Q1 revenue declined 2% to Rs 790 crore as against an estimate of Rs 789 crore.

(Source: Syngene International/Facebook)

Syngene International Ltd.'s consolidated net profit declined 18.3% in the first quarter of financial year 2025, but was in line with analysts' estimates.

The contract research and manufacturing services firm posted a net profit of Rs 76 crore in the quarter-ended June, in comparison with Rs 93 crore in the year-ago period, according to an exchange filing on Wednesday. Analysts tracked by Bloomberg had estimated a net profit of Rs 79 crore.

Syngene International Q1 FY25 Highlights (Consolidated, YoY)

  • Revenue down 2% to Rs 790 crore versus Rs 808 crore (Bloomberg estimate: Rs 789 crore).

  • Ebitda declines 23.7% to Rs 173 crore versus Rs 227 crore (Bloomberg estimate: Rs 211 crore).

  • Ebitda margin at 21.9% versus 28.1% (Bloomberg estimate: 26.8%).

  • Net profit down 18.3% to Rs 76 crore versus Rs 93 crore (Bloomberg estimate: Rs 79 crore).

Shares of Syngene International closed 2.05% lower at Rs 742.20 apiece on the BSE, as compared with a 0.28% decline in the benchmark Sensex.

Also Read: Syngene To Neuland And Laurus: Goldman Sachs Initiates Coverage As India Expands Global Pharma Supply

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google